Stocks to Watch: Vodafone Idea, Tata Communications, ICICI Lombard, Ambuja Cements and more
Vodafone Idea | The company said it has successfully secured ₹5,400 crore from 74 anchor investors. Notable among these investors are GQG Partners, The Master Trust Bank of Japan, UBS, Morgan Stanley Investment Management, Citigroup Global Markets, Australian Super, Fidelity, Quant, and Motilal Oswal.Tata Communications | The company reported a 1.5% year-on-year dip in net profit at ₹321.2 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, the company posted a net profit of ₹326 crore. Revenue from operations increased 24.6% to ₹5,691.7 crore against ₹4,568.7 crore in the corresponding period of the preceding fiscal.ICICI Lombard | Private sector non-life player on Wednesday reported a 19% year-on-year rise in net profit at ₹520 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, ICICI Lombard General Insurance posted a net profit of ₹437 crore.Ambuja Cements | The company said the Adani family has fully subscribed to the company’s warrants programme by further infusing ₹8,339 crore, bringing the total invested amount to ₹20,000 crore. With this injection of capital, the family’s stake in the company has surged by an additional 3.6%, now standing at 70.3%.Angel One | Fintech player on Wednesday reported a 27.3% year-on-year growth in net profit at ₹340 crore for the fourth quarter that ended March 31, 2024. In the corresponding quarter, Angel One posted a net profit of ₹267 crore, the company said in a regulatory filing.Shilpa Medicare | Drug firm said it has received the GMP certification from AGES, Austria, for its unit 4 facility in Jadcherla, Telangana. “Following a successful inspection, the Unit has been issued GMP Certification from Ages, Austria. The previous EU – GMP inspection for this facility was in January 2020,” it added.Brigade Enterprises | Realty firm reported an impressive financial and operational performance for the fiscal year 2023-24 (FY24), marked by record pre-sales and robust growth across its various verticals. In a milestone, the company achieved pre-sales of ₹6,013 crore in FY24.
KIMS | The hospital chain said its subsidiary SPANV Medisearch Lifesciences Private Ltd has received a demand notice under Section 156 of the Income Tax Act, 1961, for a sum of ₹306.97 crore. The notice pertains to the assessment year 2022-2023 and raises queries regarding various financial transactions.Sunteck Realty | Real estate developer announced its business update, showcasing growth in pre-sales for the fourth quarter and fiscal year 2023-24. The company reported a 26% year-on-year increase in Q4 pre-sales, amounting to ₹678 crore.Zee Entertainment | The company said it has withdrawn its application, seeking implementation of the merger with Sony, filed before the National Company Law Tribunal Mumbai bench. In a statement, ZEEL said the steps taken by it to withdraw the implementation application from NCLT are based on the legal advice received by the board.
